SKINBIOTHERAPEUTICS PLC Logo

SKINBIOTHERAPEUTICS PLC

A life science company advancing skin health by harnessing the human microbiome.

SBTX | IL

Overview

Corporate Details

ISIN(s):
GB00BF33H870
LEI:
213800YMQOCB23FX6I06
Country:
United Kingdom
Address:
THE CORE, NE4 5TF NEWCASTLE UPON TYNE

Description

SkinBioTherapeutics PLC is a life science company focused on advancing skin health by harnessing the human microbiome. Its proprietary SkinBiotix® platform technology utilizes probiotic lysates to protect, manage, and restore skin. The company develops and commercializes products across several healthcare sectors, including cosmetics, food supplements, medical devices, and pharmaceuticals. Key offerings include AxisBiotix, a probiotic food supplement designed to address psoriasis symptoms, and the Dermatonics line of specialized foot care products. Through its acquisition of Bio-Tech Solutions, the company also provides formulation, manufacturing, and packaging services for healthcare, personal care, and hygiene products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2026-01-05 08:20
Directorate change
English 18.5 KB
2026-01-02 08:25
Holding(s) in Company
English 21.0 KB
2025-12-29 15:10
Result of AGM
English 20.0 KB
2025-12-29 08:20
Holding(s) in Company
English 50.9 KB
2025-12-18 08:25
Reconfirmation of Market Guidance and AGM Q&A
English 11.9 KB
2025-12-08 15:45
Holding(s) in Company
English 50.6 KB
2025-12-08 08:35
Posting of Annual Report and AGM Notice
English 11.5 KB
2025-12-05 08:15
Final Results
English 792.6 KB
2025-11-26 08:25
Holding(s) in Company
English 50.6 KB
2025-11-19 08:25
Holding(s) in Company
English 50.6 KB
2025-11-04 16:55
Holding(s) in Company
English 50.6 KB
2025-10-14 08:00
Directorate Change
English 12.2 KB
2025-10-13 16:31
Holding(s) in Company
English 22.2 KB
2025-10-13 16:30
Holding(s) in Company
English 52.3 KB
2025-10-06 08:00
Superdrug first phase of store locations
English 38.5 KB

Automate Your Workflow. Get a real-time feed of all SKINBIOTHERAPEUTICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SKINBIOTHERAPEUTICS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SKINBIOTHERAPEUTICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.